2021
DOI: 10.1021/acs.oprd.0c00525
|View full text |Cite
|
Sign up to set email alerts
|

Large Scale Practical Synthesis of Enantiomerically Pure cis-4-Amino-3-fluoro-1-methylpiperidine via Rhodium-Catalyzed Asymmetric Hydrogenation of a Tetrasubstituted Fluoroalkene

Abstract: The development of multikilogram scale green and economical synthetic route of enantiomerically pure cis-4-amino-3-fluoro-1-methylpiperidine 1 is described. The synthesis features a highly regio-, chemo-, and enantioselective asymmetric hydrogenation of N-benzyl-4-((tert-butoxycarbonyl)amino)-5-fluoro-tetrahydropyridinium chloride 3. No purification or chiral enrichment is necessary due to the high selectivity resulting from proper selection of the catalyst system Rh(NBD) 2 (BF 4 ) and Walphos 003. The crude p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 23 publications
0
3
0
Order By: Relevance
“…As the cis -4-amino-3-fluoropiperidine moiety is a popular chiral moiety in many pharmaceutical drug candidates such as PTK2 inhibitors, JAK inhibitors, CGRP receptor antagonists, gyrase inhibitors, and antimigraine compounds, Qu and co-workers developed a highly regio-, chemo-, and enantioselective asymmetric hydrogenation for the synthesis of chiral cis -4-amino-3-fluoro-1-methylpiperidine 119 (Scheme a) . The asymmetric hydrogenation of N -benzyl-4-(( tert -butoxycarbonyl) amino)-5-fluoro-tetrahydropyridinium chloride 118 proceeded smoothly at the multikilogram scale to give 119 in 99% ee by employing a catalyst derived from Rh­(NBD) 2 (BF 4 )/ L17 .…”
Section: Asymmetric Transition Metal Catalysismentioning
confidence: 99%
“…As the cis -4-amino-3-fluoropiperidine moiety is a popular chiral moiety in many pharmaceutical drug candidates such as PTK2 inhibitors, JAK inhibitors, CGRP receptor antagonists, gyrase inhibitors, and antimigraine compounds, Qu and co-workers developed a highly regio-, chemo-, and enantioselective asymmetric hydrogenation for the synthesis of chiral cis -4-amino-3-fluoro-1-methylpiperidine 119 (Scheme a) . The asymmetric hydrogenation of N -benzyl-4-(( tert -butoxycarbonyl) amino)-5-fluoro-tetrahydropyridinium chloride 118 proceeded smoothly at the multikilogram scale to give 119 in 99% ee by employing a catalyst derived from Rh­(NBD) 2 (BF 4 )/ L17 .…”
Section: Asymmetric Transition Metal Catalysismentioning
confidence: 99%
“…An alternative strategy involves transition-metal-catalyzed asymmetric cross-couplings of F-incorporated motifs, such as fluorinated enolates (or their equivalents) and α-fluoro alkyl halides, to form the desired C–F stereocenters . Moreover, alkenyl fluorides, one of the most readily available F-containing building blocks, have also been explored as simple precursors for stereodefined C­(sp 3 )–F motifs, typically via catalytic asymmetric hydrogenation . Recently, Sigman et al, via Pd-catalyzed asymmetric remote hydroarylation, and Fu et al, via Co-catalyzed asymmetric hydroalkylation with alkyl halides, have disclosed two examples of catalytic asymmetric hydrofunctionalization of alkenyl fluorides (Figure a).…”
Section: Introductionmentioning
confidence: 99%
“…The rich chemistries afforded by homogeneous Rh­(I) catalysis have been studied within academia for decades and more recently have attracted attention within process research and development in the fine chemical industry. For example, Rh­(I)-catalyzed hydrogenation has been a popular transformation on process scale, and other industrial applications include Rh­(I)-catalyzed hydroformylation, conjugate addition, C–H functionalization, and transfer hydrogenation …”
Section: Introductionmentioning
confidence: 99%